Bellicum Pharma (BLCM) Reports Q4 Loss of $0.63/Share

Bellicum Pharma (NASDAQ: BLCM) reported Q4 EPS of ($0.63), versus ($0.66) reported last year.

For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79